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Abstract
It is known that big-h3 is involved in the invasive process of many types of tumors, but its mechanism in glioma cells has not
been fully clarified. Using immunofluorescent double-staining and confocal imaging analysis, and co-immunoprecipitation
assays, we found that big-h3 co-localized with integrin a5b1 in U87 cells. We sought to elucidate the function of this
interaction by performing cell invasion assays and gelatin zymography experiments. We found that siRNA knockdowns of
big-h3 and calpain-2 impaired cell invasion and MMP secretion. Moreover, big-h3, integrins and calpain-2 are known to be
regulated by Ca
2+, and they are also involved in tumor cell invasion. Therefore, we further investigated if calpain-2 was
relevant to big-h3-integrin a5b1 interaction to affect U87 cell invasion. Our data showed that big-h3 co-localized with
integrin a5b1 to enhance the invasion of U87 cells, and that calpain-2, is involved in this process, acting as a downstream
molecule.
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Introduction
Gliomas have a high incidence rate, and represent the most
common form of primary intracranial tumors. They are generally
malignant and highly invasive to surrounding structures, and
prognosis is largely correlated with tumor stage. Because of these
fatal characteristics, it is hard to perform complete resection by
surgery. Although much work has been done to find clues as to
invasive biomarkers and effective treatment methods, the molec-
ular mechanisms need to be further investigated [1].
Transforming growth factor (TGF)-b-inducible gene-h3 (big-h3)
is widely expressed in various types of tumor cells. Though it is not
normally expressed in tissues of the central nervous system, it was
demonstrated to be expressed in U87 human astrocytoma cells
[2,3]. According to its molecular structure and functions, different
names have been assigned to the protein, such as TGFBI, RGD-
CAP, and MP78/70. Previous studies have demonstrated that by
interacting with integrin a3b1 or regulating store-operated Ca
2+
entry, big-h3 promotes the migration and invasive ability of tumor
cells [4,5,6]. However, the role of big-h3 in affecting glioma cell
invasion in the transduction pathway remains to be investigated.
Integrins are transmembrane heterodimers composed of a and
b chains that provide physical and functional links between cell-
cell and cell-ECM (extracellular matrix) interactions to mediate
many cellular activities in tumors [7,8,9]. As we know, the
interaction of integrins with ECM is related to cell viability and
invasion. Proteins such as EMMPRIN (extracellular matrix
metalloproteinase inducer) can interact with integrins to enhance
the progression of hepatoma cells [10,11]. In the present study, we
found that big-h3 co-localized with integrin a5b1 in U87 cells.
However, very little information is available regarding the
potential roles of this phenomenon. Given that big-h3 and
integrin can be involved in tumor invasion, the interaction of
big-h3 with integrin a5b1 may also affect the invasion of U87 cells.
Cell invasion is a characteristic of most malignant tumors, and
in glioma cells this process is often mediated by calpain-2,
a calcium-dependent thiol proteinase, which consists of a catalytic
subunit and a regulatory subunit [12,13]. It can be activated by
millimolar levels of Ca
2+ to enhance tumor invasion [14,15,16].
We presume that Ca
2+ is the ‘‘key point’’ among big-h3, integrin
a5b1 and calpain-2, and therefore attempted to elucidate this
relationship.
In the present study, we showed that big-h3 and integrin a5b1
form a complex, and that they activate MMP secretion and
enhance invasive potential via its downstream molecule calpain-2
in U87 cells.
Results
siRNA knockdowns can inhibit the expression of big-h3
and calpain-2 in U87 cells
Previous studies have shown that big-h3 and calpain-2 are
expressed in U87 cells [2,3,12]. To obtain further information
about their roles, small interfering RNAs (siRNAs) were
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calpain-2 RNA and protein expression. Silencer negative control
siRNAs (Snc-RNAs) were also used as a negative control,
according to the manufacturer’s protocol. As compared with
snc-RNA treated cells, the siRNA knockdowns could effectively
decrease the mRNA expression of big-h3 and calpain-2
(47.9%64.1% and 51.1%63.5%, respectively), and the protein
expression of big-h3 and calpain-2 was significantly reduced to
43.4%66.5% and 34.6%62.0% (P,0.01, Figure 1A–1D).
Downregulation of big-h3 and calpain-2 decreases MMP
secretion and U87 cell invasion
big-h3 and calpain-2 promote invasion in tumor cells and they
also enhance MMP secretion potential which is implicated in
promoting metastasis by degradation of ECM. To further test for
the ability to specifically suppress big-h3 and calpain-2, we
analyzed the expression level of MMPs and their invasive ability
following knockdown of big-h3 and calpain-2 in U87 cells. Snc-
RNAs were also used as a negative control, according to the
manufacturer’s protocol. The results showed that these knock-
downs reduced the density of MMPs and the invasive potential of
U87 cells (P,0.01, Figure 2A–2D).
big-h3 co-localizes with integrin a5b1 on U87 cell
membranes
The invasive ability of human hepatoma cells is enhanced by
the interaction of big-h3 with integrin a3b1 [5]. According to the
study, we hypothesized that big-h3 might interact with integrin
a5b1 to affect the invasive ability of U87 cells. So we performed
immunofluorescent double-staining and confocal imaging analysis
to examine cellular distribution. The results showed that staining
overlapped diffusely throughout the surface of U87 cells
(Figure 3A). To further confirm this result, Co-immunoprecipita-
tion experiments were performed to detect the immunoreactivity
of big-h3 and the integrin a5 and b1 subunits. As Figure 3B–3E
indicates, big-h3 and integrin a5b1 interacted in their native
conformations in U87 cell lysates.
Interaction of big-h3 with integrin a5b1 mediates MMP
secretion and cell invasion potential
To identify the function of the interaction of big-h3 with
integrin a5b1, antibodies against the integrin subunits and big-h3
were used. Integrin a5b1, which is composed of an a5 chain and
a b1 chain, is a receptor for fibronectin that is a component of
ECM. It recognizes the sequence Arg-Gly-Asp (RGD) in its
ligands. The ‘‘function blocking’’ antibodies, mouse anti-human
a5 mAb (P1D6) and mouse anti-human b1 mAb (3S3), neutralize
binding of a5b1 to the central cell adhesion domain of fibronectin.
Such reaction may result in decrease of invasion potential and
MMP secretion [17–20]. We treated U87 cells with P1D6, 3S3,
P1D6+3S3 and si-big-h3 for 36 h, and then examined the invasive
ability and the presence of MMPs. As shown in Figure 4A and 4B,
no significant cell number and MMP density changes were found
between the snc-RNA transfected alone groups and the no
antibody treated groups (P.0.01). As compared with the snc-RNA
treated alone cells, invasive potential were markedly decreased
after treated with P1D6, 3S3 or P1D6+3S3 (P,0.01), but no
significant difference were found in the groups, including
blank+P1D6, blank+3S3, blank+P1D6+3S3, snc-RNA+P1D6,
snc-RNA+3S3 and snc-RNA+P1D6+3S3 groups (P.0.01). Sim-
ilar results were observed in big-h3 siRNA transfected alone
groups compared with snc-RNA treated alone groups and the no
antibody treated groups (P,0.01), but there were no significant
differences in comparison with blank+P1D6, blank+3S3,
blank+P1D6+3S3, snc-RNA+P1D6, snc-RNA+3S3 and snc-
RNA+P1D6+3S3 groups (P.0.01). The addition of antibodies
Figure 1. Effects of silencing big-h3 and calpain-2 in U87 cells. Thirty-six hours after si-big-h3 or snc-RNA transfection of U87 cells, RT-PCR (A)
and western blotting (B) were performed to test the mRNA and protein levels of big-h3. U87 cells treated with si-big-h3 significantly reduced the
mRNA expression of big-h3 to 47.9%64.1%, and reduced the protein expression of big-h3 to 43.4%66.5% in comparison to the snc-RNA treated cells
(P,0.01). Thirty-six hours after si-calpain-2 or snc-RNA transfection of U87 cells, RT-PCR (C) and western blotting (D) were performed to test the mRNA
and protein levels of calpain-2. U87 cells treated with si-calpain-2 significantly reduced the mRNA expression of calpain-2 to 51.1%63.5%, and
reduced the protein expression of calpain-2 to 34.6%62.0% in comparison to the snc-RNA treated cells (P,0.01). Data are representative of three
independent experiments. Bars represent the mean of triplicate samples and error bars represent standard deviation. *p,0.01 versus corresponding
cells with snc-RNA treatment.
doi:10.1371/journal.pone.0037297.g001
big-h3-Integrin-a5b1-Calpain-2 Pathway in U87 Cell
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secretion in big-h3 siRNA transfected cells, compared with the
cells treated with big-h3 siRNA alone (P.0.01). These results
indicated that big-h3 and integrin a5b1 were both required for
and dependent upon the invasion of U87 cells.
Calpain-2 is a downstream signaling molecule of big-h3-
mediated invasion involving a5b1
We used western blotting analysis, Reverse transcriptase
polymerase chain reaction (RT-PCR) assay and invasion assay
to test if calpain-2 is upstream or downstream of big-h3 and
Figure 2. Effects of silencing big-h3 and calpain-2 on MMPs secretion and invasion. Thirty-six hours after si-big-h3 or snc-RNA transfection
of U87 cells, Gelatin zymography (A) and invasion assay (B) were performed to test MMP secretion and invasive potential. Thirty-six hours after si-
calpain-2 or snc-RNA transfection of U87 cells, Gelatin zymography (C) and invasion assay (D) were performed to test MMP secretion and invasive
potential. Data are representative of three independent experiments. Bars represent the mean of triplicate samples and error bars represent standard
deviation. *p,0.01 versus corresponding cells with snc-RNA treatment. Bar =100 um.
doi:10.1371/journal.pone.0037297.g002
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PLoS ONE | www.plosone.org 3 May 2012 | Volume 7 | Issue 5 | e37297Figure 3. Expression and immunoprecipitation of big-h3 and integrin a5b1 in U87 cells. (A) U87 cells were double-stained for big-h3 (red)
and integrin a5o rb1 (green). (B) Expression of big-h3 and integrin a5 and b1 subunits in U87 cell lysates. (C) Precipitates from big-h3
immunocomplexes were detected for precipitated integrin a5 and b1 subunits. Mouse IgG was used as a negative control. Precipitates from a5 (D) or
b1 (E) immunocomplexes were detected for precipitated big-h3. Mouse IgG was used as a negative control. Bar =50 um.
doi:10.1371/journal.pone.0037297.g003
Figure 4. Invasive potential of U87 cells with or without integrin a5b1 mAbs and si-big-h3 treatment. After treated with si-big-h3 or snc-
RNA, U87 cells were treated with P1D6, 3S3, or P1D6+3S3 for thirty-six hours. Gelatin zymography (A) and invasion assay (B) were performed to test
MMP secretion and invasive potential. Data are representative of three independent experiments. Bars represent the mean of triplicate samples and
error bars represent standard deviation. *p,0.01 versus corresponding cells with no antibody treatment. Bar =100 um.
doi:10.1371/journal.pone.0037297.g004
big-h3-Integrin-a5b1-Calpain-2 Pathway in U87 Cell
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expression of big-h3 was not changed following calpain-2 siRNA
knockdown (P.0.01, Figure 5A and 5B), but the mRNA and
protein expression of calpain-2 was decreased when U87 cells were
treated with big-h3 siRNA, (P,0.01, Figure 5C and 5D). And the
mRNA and protein expression of calpain-2 was decreased when
U87 cells were treated with P1D6, 3S3 and P1D6+3S3 (P,0.01,
Figure 5E and 5F). As compared with the snc-RNA treated alone
groups, invasive potential was obviously decreased after treated
with si-big-h3, si-calpain-2 or si-big-h3+si-calpain-2 (P,0.01), but
no significant difference were found in the groups, including snc-
RNA+si-big-h3, si-calpain-2 and si-big-h3+si-calpain-2 groups
(P.0.01, Figure 5G). All of these results suggest that calpain-2
acts downstream of big-h3 and a5b1 integrin to influence invasion
of U87 cells.
Discussion
Studies of the molecular mechanism of invasion could reveal
targets for glioma treatment. big-h3, a 68 kDa extracellular matrix
protein mainly induced by transforming growth factor-b (TGF-b),
was first identified in the human lung adenocarcinoma cell line
A549 [21]. It is expressed in many cells and tissues including the
heart, liver, stomach, skeletal muscle and kidney [6,21,22].
Although its roles are largely unknown, it has been suggested that
it involves in the regulation of many aspects of tumor cell
processes, including cell adhesion, spreading, invasion, prolifera-
tion and apoptosis [22–25]. It has also been associated with
corneal dystrophy, wound healing, atherosclerosis and many other
human diseases [2,26]. It contains four repetitive FAS-1 domains
and an integrin recognition site named RGD sequence which can
serve as a ligand of integrins. In this study, we focused on the
receptors for big-h3, the roles of which still remain largely
unknown and tested if they could influence the invasive ability of
U87 cells. The results presented here show that big-h3 enhances
the invasive potential of U87 cells by interacting with integrin
a5b1.
Integrins, a large family of cell matrix adhesion receptors, have
been demonstrated to play important roles in many types of tumor
cells. Through the interaction with the basement membrane,
integrins can mediate adhesion and invasion [8,25,27]. Previous
studies have shown that integrin a6b1 can enhance the
aggressiveness of U87 glioma cells, and the apoptosis of Ntera2
neuronal cells, which are being evaluated to employ in central
nervous system (CNS) transplantation, was delayed by the
activation of integrin a5b1 [8,28]. In particular, integrin a5-
laminins can highly enhance the invasion of all types of glioma
cells, and the migration of U251 glioma cells is downregulated by
fibronectin, an ECM ligand of integrin a5b1 [29,30]. Therefore, it
was not surprising that integrin inhibitors serve as a potential drug
to prevent tumor cell invasion. JSM6427 and SJ749, inhibitors of
integrin a5b1, attenuate glioma cell proliferation and invasion
[22,31]. In the present study, we demonstrated that big-h3 was
positively related to the expression of integrin a5b1 and there are
no previous reports about the signaling mechanism of big-h3-
integrin a5b1 interaction. We further observed that antibodies to
a5 and/or b1 could effectively reduce big-h3-mediated invasion
and MMP secretion, and provided no significant additional
inhibitory effect in U87 cells. Hence, we proposed a hypothesis
that big-h3 interaction with integrin a5b1 can regulate invasion of
U87 cells.
big-h3 plays key roles in tumor cell invasion and previous study
has demonstrated that it increases Ca
2+ influx to enhance secretion
of MMPs [4]. Ca
2+ is known to be involved in the motility,
apoptosis, proliferation of cancer cells, as well as invasion [32,33].
Focal adhesion kinase (FAK), mitogen-activated protein kinase
(MAPK) and extracellular regulated protein kinase (ERK) are
crucial components in the signaling pathways of some integrins,
and all may influence Ca
2+ accumulation. Specific inhibitors of
these proteins can not only affect Ca
2+ concentration and its
signaling pathway, but significantly block integrin-induced or big-
h3-induced invasion and MMP release. Calpains are proteins that
belong to the family of calcium-dependent intracellular cysteine
proteases, and are ubiquitously expressed in glioma cells. These
include m- and m-isozymes, and are involved in the degradation of
the main components of matrix and glycan, which are correlated
with many diseases such as Alzheimer’s and stroke [13,34].
Downregulation of calpains after transfection with calpain-1 (m-
calpain) or calpain-2 (m-calpain) siRNA could reduce the secretion
of MMPs and attenuate the adhesive and invasive potentials of
some tumor cells [35,36]. ERK and MAPK are upstream
molecules of calpains, and FAK is a common substrate [37,38].
Thus, Ca
2+ might be a ‘‘medium’’ to affect the invasive ability
promoted by big-h3, integrin a5b1 and calpain-2, and the precise
mechanism remains to be elucidated. We speculate that big-h3
enhances the invasion potential of U87 cells via integrin a5b1-
calpain-2 signaling pathways.
Our data demonstrates that big-h3 activates MMP secretion
and promotes invasive potential by interacting with integrin a5b1
via its downstream molecule calpain-2 in U87 cells. These results
are significant in that they suggest that mechanisms regulating big-
h3-a5b1 interactions, and their role towards calpain-2 signaling
may constitute a novel anti-glioma drug target.
Materials and Methods
Cell culture
Human U87 astrocytoma cell line, which was purchased from
the Type Culture Collection of the Chinese Academy of Sciences
(Shanghai, China), were routinely grown in Dulbecco’s Modified
Eagle’s Medium (DMEM) plus 10% fetal bovine serum (FBS) at
37uC in a humidified atmosphere of 5% CO2 incubators.
Gene silencing of big-h3 and calpain-2
U87 cells were transfected with big-h3 siRNA (si-big-h3) and
calpain-2 siRNA (si-calpain-2) using Lipofectamine 2000 reagent
(Invitrogen, USA) according to the manufacturer’s protocol. snc-
RNA (Ambion, USA) was used as negative control under similar
conditions. The sequences of siRNA duplex targeting big-h3 were
as following: 59-CCUUUACGAGACCCUGGGATT-39 and 59-
UCCCAGGGUCUCGUAAAGGTT-39 (Ambion, USA). And
the siRNA sequence for calpain-2 was: GCGAGGACATGCA-
CACCAT (GenePharma, China). Silencing effects were examined
by RT-PCR and western blotting analysis.
RT-PCR
Thirty-six hours after siRNAs transfection, U87 cells were
collected to verify the mRNA expression by RT-PCR. Total RNA
was extracted using Trizol reagent (Invitrogen, USA) and first-
strand complementary DNA (cDNA) was reverse transcribed using
the ReverTra Ace kit (Toyobo, China) according to the guidelines.
The cDNA was used as the template and was amplified by PCR
using a specific primer set for big-h3 and calpain-2, and b-actin
was used as the internal control to normalize variances. All
primers and probes were Synthesized by Shanghai Sangon Co.
The primers used were as follows: big-h3, 59-CATTGAGAA-
CAGCTGCATCG-39 (forward) and 59-
AGTCTGCTCCGTTCTCTTGG-39 (reverse); calpain-2, 59-
big-h3-Integrin-a5b1-Calpain-2 Pathway in U87 Cell
PLoS ONE | www.plosone.org 5 May 2012 | Volume 7 | Issue 5 | e37297Figure 5. The expression of calpain-2 and big-h3 after si-big-h3, si-calpain-2 or integrin a5b1 mAbs treatment. Thirty-six hours after si-
calpain-2 treatment, RT-PCR (A) and western blotting (B) were performed to test the mRNA and protein levels of big-h3. Thirty-six hours after si-big-h3
treatment, RT-PCR (C) and western blotting (D) were performed to test the mRNA and protein levels of calpain-2. Thirty-six hours after P1D6, 3S3 and
P1D6+3S3 treatment, RT-PCR (E) and western blotting (F) were performed to test mRNA and protein levels of calpain-2. (G) Thirty-six hours after si-
big-h3 and si-calpain-2 treatment, alone or in combination, invasion assay was also performed to test invasive potential. Data are representative of
three independent experiments. Bars represent the mean of triplicate samples and error bars represent standard deviation. *p,0.01 versus
corresponding cells with snc-RNA or no antibody treatment. Bar =100 um.
doi:10.1371/journal.pone.0037297.g005
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CTCCACCCACTCGCCGTA-39 (reverse); b-actin, 59-
CCCAGCCATGTACGTTGCTA-39 (forward) and 59-
TCACCGGAGTCCATCACGAT-39 (reverse). PCR was carried
out under the following conditions: 5min denaturation at 94uC,
renaturation for 30 cycles at 94uC for 30s, 57uC for 30s, 72uC for
30s and 7 min extension at 72uC. The products were finally
separated on 1% agarose gels and were analyzed by ultraviolet
light.
Western blotting analysis
Thirty-six hours after siRNAs transfection, the conditioned
medium of the U87 cells was collected. After BCA protein assay,
equal amounts of protein were separated on 10% sodium dodecyl
sulfate polyacrylamide gel electrophoresis (SDS-PAGE). Proteins
were separated by electrophoresis and transferred onto a poly-
vinylidene fluoride (PVDF) membrane (Millipore). After being
blocked with 5% non-fat milk and washed with TBS-T, the
immunoblots were incubated with the designated antibodies.
Signals were detected using the Western-Light chemiluminescent
detection system (Applied Biosystems). And b-actin was chosen as
the internal control.
Co-immunoprecipitation and western blotting analysis
For immunoprecipitation, the interaction of big-h3 with
integrin a5b1 was detected by the ProFoundTM Mammalian
Co-Immunoprecipitation Kit (Pierce, USA). U87 cells were
collected and lysed by M-per reagent. Lysates were incubated
with mouse anti-human big-h3 mAb or mouse anti-human a5
mAb (P1D6) (Chemicon) and mouse anti-human b1 mAb (3S3)
(Santa Cruz). And then bound proteins were collected onto
a coupling gel to elute. After that, by western blotting, the elution
was resolved by SDS-PAGE, and then blotted and probed with the
designated antibodies to detect integrin a5b1o rbig-h3. HRP-
conjugated rabbit anti-goat IgG (Amersham Pharmacia) was used
as the negative control.
Immunofluorescence and confocal microscopy
For the detection of the location of big-h3 and integrin a5b1,
after placed onto glass coverslips overnight, U87 cells were fixed in
4% paraformaldehyde in (Phosphate Buffered Saline) PBS and
then were pre-incubated with 1% bovine serum albumin (BSA) in
PBS for 1h. Coverslips were treated with the primary antibodies
(Santa Cruz) at a 1:200 dilution in PBS for 1h in a humid
chamber. Primary antibody-treated cells were washed in PBS and
then incubated with fluorescein isothiocyanate (FITC)–conjugated
donkey anti-goat secondary antibodies (Santa Cruz) at a 1:500
dilution in PBS for 1 h. Cell nuclei were stained with DAPI
(Biotium, USA) for 10 min at 37uC. Finally, the cells were
enveloped with glycerol and observed by FV1000 laser scanning
confocal microscope (Olympus).
Invasion assay
The assay was performed using 24-well Transwell units with
a polycarbonate filter (8-mm pore size, Millipore) coated on the
upper side with Matrigel at a concentration of 5 mg/ml to form
a thin layer. Each lower chamber contained 600 ml of 0.5% FBS
as the chemoattractant. After siRNAs transfection, U87 cells were
harvested to put into the upper chamber and then incubated for
36 h at 37uC in a humid atmosphere containing 5% CO2. After
incubation, non-migrating cells on the top of the chambers were
completely removed by a cotton swab. Cells that invaded into the
lower chambers were fixed in 95% methanol for 5 min and then
determined using a colorimetric crystal violet assay.
Gelatin zymography
Thirty-six hours after siRNAs transfection, the sample protein,
which was extracted from the conditioned media and was mixed
with sample buffer, was separated by 8% acrylamide gels
containing 0.1% gelatin. The gels were washed in 2.5% Triton
X-100 (Sigma, USA) solution for 15mins twice at room
temperature with gentle agitation to remove SDS and were then
soaked into reaction buffer (0.05 mol/l Tris-HCl pH 7.5, 0.2 mol/
l NaCl, and 0.01 mol/l CaCl2)a t3 7 uC overnight. The gels were
stained with Coomassie brilliant blue for 6 h and were then
destained for 0.5 h. The expression and activation of MMP were
shown by negative staining.
Statistical analysis
Statistical analysis was performed using SPSS 13.0 statistical
software. The results were expressed as mean values 6 SD. And
one-way ANOVA was used to evaluate the statistical significance
among the groups. The differences were considered significant
when P,0.01.
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